XPAR
CLARI
Market cap1.31bUSD
Oct 09, Last price
3.32EUR
1D
2.79%
1Q
-16.37%
Jan 2017
-88.07%
IPO
-90.70%
Name
Korian SE
Chart & performance
P/E
—
P/S
—
EPS
0.00
Div yield, %
—
Shrs. gr., 5y
27.44%
Rev. gr., 5y
7.08%
Revenues
5.31b
+0.54%
Net income
2m
P
CFO
796m
-11.51%
Dividend
Jun 21, 20230.25 EUR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Clariane SE, established in Paris, France, in 2001 and known as Korian until its rebranding in June 2023, specializes in delivering comprehensive medical and non-medical care and support. The company serves senior citizens and individuals facing either temporary or chronic health challenges through a diverse range of provisions. These offerings encompass residential facilities like long-term nursing homes, specialized medical clinics, and senior living communities, including assisted living and co-housing arrangements. Furthermore, Clariane extends its services to include in-home care, various support programs, and hospitalization. Its operational footprint spans multiple European nations, including France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
Related entities
Subsidiaries (19)
CLARIANE & PARTENAIRES IMMOBILIER 2
KINETIKA SARDEGNA S.R.L.
KORIAN BELGIUM
OPPCI CLARIANE IMMOBILIER
SANTA CROCE S.R.L.
SEGESTA S.P.A. S.B.
SILVER IMMOBILIARE S.R.L.
SL FINANCE
"IL CHIOSCO SRL"
ASSISI PROJECT SOCIETA' PER AZIONI
CLARIANE & PARTENAIRES IMMOBILIER 1
CLARIANE IMMOBILIER ALLEMAGNE 6
GERESS SOCIETA' A RESPONSABILITA' LIMITATA", IN FORMA ABBREVIATA "GERESS S.R.L."
ISAV S.P.A.
ITALIAN HOSPITAL GROUP SPA
KORIAN CONCESIONES 2022 SL
MSH S.R.L.
RSA BERZO INFERIORE S.R.L.
RSA BORNO SOCIETA' DI PROGETTO SPA
Key people
Remi Boyer
Deputy Chief Executive Officer, Executive Vice President - Germany, Member of the Management Board · since 2024
Gregory Lovichi
Group Financial Officer, Member of the Management Board · since 2024
Nadege Plou
Group Human Resources Officer · since 2024
Charles-Antoine Pinel
Group Executive Vice President - Business Development and New Countries, Member of the Management Board · since 2022
Chief Executive Officer, Director, Member of the Management Board · since 2020
Guillaume Appere
Member of the Management Board, Group General Secretary · since 2024
Dominiek Beelen
Member of the Management Board, Managing Director of Korian, Benelux · since 2024
Marion Cardon
Managing Director of Korian, France, Member of the Management Board · since 2025
Frederic Durousseau
Member of the Management Board, Group Chief Real Estate and Development Officer · since 2021
Anne-Charlotte Dymny
Chief Information Technology Officer, Member of the Management Board and Chair of Clariane, Spain · since 2024
Federico Guidoni
Member of the Management Board, Managing Director of Korian, Italy · since 2024
Nicolas Merigot
Member of the Management Board, Executive Vice President, France · since 2022
Nicolas Pecourt
Member of the Management Board, Group Communications Director · since 2022
Antoine Piau
Member of the Management Board, Senior Vice President - Medical, Ethics and Health Innovation · since 2023
Hortense De Lamaze
Executive Secretary to the General Management Board · since 2023
Florence Barjou
Director - Representative of Predica · since 2022
Jean-Bernard Lafonta
Institutional Directors · since 2024
Matthieu Lance
Institutional Director · since 2024
Julie Le Goff
Director - Representative of HLD Europe · since 2024
Marie-Christine Leroux
Director - Employees Representative · since 2019
Headquarters & legal address
21 RUE BALZAC
21-25
PARIS 75008
FR
21-25
PARIS 75008
FR
Previous name
KORIAN
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT |